MAPT and Alzheimer disease: DBS increased the level of synaptophysin in the CA1 region of AD mice. Synaptic activation promoted the clearance of Tau oligomers by autophagosomes and lysosomes, thereby reducing the level of Tau oligomers in the CA1 of AD mice.